Terms: = Liver cancer AND ABCG2, ABC15, ABCP, BCRP, BCRP1, BMDP, CD338, CDw338, EST157481, GOUT1, MRX, MXR, MXR-1, MXR1, UAQTL1 AND Prognosis
17 results:
1. Identification of Prognostic Factors in Cholangiocarcinoma Based on Integrated ceRNA Network Analysis.
Jin H; Liu W; Xu W; Zhou L; Luo H; Xu C; Chen X; Chen W
Comput Math Methods Med; 2022; 2022():7102736. PubMed ID: 36158120
[TBL] [Abstract] [Full Text] [Related]
2. FZD7 accelerates hepatic metastases in pancreatic cancer by strengthening EMT and stemness associated with TGF-β/SMAD3 signaling.
Zhang Z; Xu Y
Mol Med; 2022 Jul; 28(1):82. PubMed ID: 35854234
[TBL] [Abstract] [Full Text] [Related]
3. SOX9 enhances sorafenib resistance through upregulating abcg2 expression in hepatocellular carcinoma.
Wang M; Wang Z; Zhi X; Ding W; Xiong J; Tao T; Yang Y; Zhang H; Zi X; Zhou W; Huang G
Biomed Pharmacother; 2020 Sep; 129():110315. PubMed ID: 32554246
[TBL] [Abstract] [Full Text] [Related]
4. Activation of LXRɑ/β by cholesterol in malignant ascites promotes chemoresistance in ovarian cancer.
Kim S; Lee M; Dhanasekaran DN; Song YS
BMC Cancer; 2018 Dec; 18(1):1232. PubMed ID: 30526541
[TBL] [Abstract] [Full Text] [Related]
5. Irinotecan toxicity during treatment of metastatic colorectal cancer: focus on pharmacogenomics and personalized medicine.
Paulík A; Nekvindová J; Filip S
Tumori; 2020 Apr; 106(2):87-94. PubMed ID: 30514181
[TBL] [Abstract] [Full Text] [Related]
6. NEK2 regulates stem-like properties and predicts poor prognosis in hepatocellular carcinoma.
Lin S; Zhou S; Jiang S; Liu X; Wang Y; Zheng X; Zhou H; Li X; Cai X
Oncol Rep; 2016 Aug; 36(2):853-62. PubMed ID: 27349376
[TBL] [Abstract] [Full Text] [Related]
7. abcg2 Overexpression Confers Poor Outcomes in Hepatocellular Carcinoma of Elderly Patients.
Chen YL; Chen PM; Lin PY; Hsiau YT; Chu PY
Anticancer Res; 2016 Jun; 36(6):2983-8. PubMed ID: 27272814
[TBL] [Abstract] [Full Text] [Related]
8. cancer stem-like cell behavior in anaplastic thyroid cancer: A challenging dilemma.
Haghpanah V; Fallah P; Naderi M; Tavakoli R; Soleimani M; Larijani B
Life Sci; 2016 Feb; 146():34-9. PubMed ID: 26772823
[TBL] [Abstract] [Full Text] [Related]
9. CES2, abcg2, TS and Topo-I primary and synchronous metastasis expression and clinical outcome in metastatic colorectal cancer patients treated with first-line FOLFIRI regimen.
Silvestris N; Simone G; Partipilo G; Scarpi E; Lorusso V; Brunetti AE; Maiello E; Paradiso A; Mangia A
Int J Mol Sci; 2014 Sep; 15(9):15767-77. PubMed ID: 25198900
[TBL] [Abstract] [Full Text] [Related]
10. Patients with CD133-negative colorectal liver metastasis have a poor prognosis after hepatectomy.
Yamamoto S; Tanaka K; Takeda K; Akiyama H; Ichikawa Y; Nagashima Y; Endo I
Ann Surg Oncol; 2014 Jun; 21(6):1853-61. PubMed ID: 24554065
[TBL] [Abstract] [Full Text] [Related]
11. Molecular prognostic profile of Egyptian HCC cases infected with hepatitis C virus.
Zekri AR; Hassan ZK; Bahnassy AA; Sherif GM; ELdahshan D; Abouelhoda M; Ali A; Hafez MM
Asian Pac J Cancer Prev; 2012; 13(11):5433-8. PubMed ID: 23317196
[TBL] [Abstract] [Full Text] [Related]
12. Circulating stem cell-like epithelial cell adhesion molecule-positive tumor cells indicate poor prognosis of hepatocellular carcinoma after curative resection.
Sun YF; Xu Y; Yang XR; Guo W; Zhang X; Qiu SJ; Shi RY; Hu B; Zhou J; Fan J
Hepatology; 2013 Apr; 57(4):1458-68. PubMed ID: 23175471
[TBL] [Abstract] [Full Text] [Related]
13. Sal-like protein 4 (SALL4), a stem cell biomarker in liver cancers.
Oikawa T; Kamiya A; Zeniya M; Chikada H; Hyuck AD; Yamazaki Y; Wauthier E; Tajiri H; Miller LD; Wang XW; Reid LM; Nakauchi H
Hepatology; 2013 Apr; 57(4):1469-83. PubMed ID: 23175232
[TBL] [Abstract] [Full Text] [Related]
14. Breast cancer resistance protein expression is associated with early recurrence and decreased survival in resectable pancreatic cancer patients.
Lee SH; Kim H; Hwang JH; Lee HS; Cho JY; Yoon YS; Han HS
Pathol Int; 2012 Mar; 62(3):167-75. PubMed ID: 22360504
[TBL] [Abstract] [Full Text] [Related]
15. High expression of ABCC1 indicates poor prognosis in intrahepatic cholangiocarcinoma.
Srimunta U; Sawanyawisuth K; Kraiklang R; Pairojkul C; Puapairoj A; Titipungul T; Hahnvajanawong C; Tassaneeyakul W; Wongkham C; Wongkham S; Vaeteewoottacharn K
Asian Pac J Cancer Prev; 2012; 13 Suppl():125-30. PubMed ID: 23480753
[TBL] [Abstract] [Full Text] [Related]
16. c-Met represents a potential therapeutic target for personalized treatment in hepatocellular carcinoma.
You H; Ding W; Dang H; Jiang Y; Rountree CB
Hepatology; 2011 Sep; 54(3):879-89. PubMed ID: 21618573
[TBL] [Abstract] [Full Text] [Related]
17. High expression levels of putative hepatic stem/progenitor cell biomarkers related to tumour angiogenesis and poor prognosis of hepatocellular carcinoma.
Yang XR; Xu Y; Yu B; Zhou J; Qiu SJ; Shi GM; Zhang BH; Wu WZ; Shi YH; Wu B; Yang GH; Ji Y; Fan J
Gut; 2010 Jul; 59(7):953-62. PubMed ID: 20442200
[TBL] [Abstract] [Full Text] [Related]
